Past Advisory Board
Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board:
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.
Dominic Adair
Partner
Bristows LLP (U.K)
Monika Dorda
SVP & General Counsel Global Pharmaceuticals
GSK
Dr. Sabrina Duschner
VP Patent Litigation Strategy
Fresenius Kabi Deutschland GmbH
Bert Oosting
Partner
Hogan Lovells
Guido Pontremoli, Ph.D.
Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.
Laura Reynolds
Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals
